Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MCK | EQNR |
|---|---|---|
| Price | $877.59 | $43.22 |
| Change today | ▼ 0.33% | ▲ 0.75% |
| Market cap | $102.32B | $102.46B |
| Return, 3 months | +14.6% | +38.1% |
| Return, year to date | +7.3% | +89.1% |
| Return, 1 year | +15.8% | +76.6% |
| P/E (TTM) | 23.4 | 11.7 |
| P/B | -24.1 | 2.4 |
| P/E percentile vs own 5y | 38th | 79th |
| Dividend yield | 0.37% | 3.47% |
| Revenue growth (YoY, latest qtr) | +7.7% | +37.4% |
| Net profit growth (YoY) | +24.2% | +267.2% |
| Gross margin | 3.6% | 40.4% |
| Operating margin | 1.7% | 28.0% |
| Net margin | 1.1% | 8.0% |
| Return on equity | – | 21.3% |
| Analyst target vs. price | +14.0% | -14.4% |
| Analyst buy share | 83% | 0% |
| RSI (14) | 56 | 51 |
| 30-day volatility | 27.1% | 32.7% |
| Max drawdown, 1 year | -27.2% | -26.1% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.